UK's Flok Health Secures $12.5 Million to Expand AI Physiotherapy Platform
Flok Health, an AI-driven digital physiotherapy platform, has oversubscribed its Series A funding ro...
UK QCS Acquires CareBrain to Accelerate Care Sector Transformation
QCS (Quality Compliance Systems) recently announced the acquisition of CareBrain, a technology trans...
University of California and University of Oxford Develop Wearable Ultrasound Patch for Continuous Fetal Monitoring
A soft, adhesive ultrasound patch can continuously track fetal blood flow and structure, a study pub...
Singapore's Angel Eye Introduces AI Retinal Screening for Preoperative Assessment
On June 3, 2026, Angel Eye & Cataract Centre integrated the ZEISS CIRRUS PathFinder system into its ...
Tunisia Achieves Local Production of Key Radiopharmaceutical for Prostate Cancer
With support from the International Atomic Energy Agency (IAEA), Tunisia has achieved local producti...
French Team Develops Otosurg 3D-Printed Ear Surgery Simulator
A collaborative team in France has developed Otosurg, a multi-material 3D-printed ear surgery simula...
QuantiPath Adds Dr. Stephens to Expand Food Safety Team
Denver-based biotechnology company QuantiPath announced on June 3, 2026, that Dr. Tyler Stephens has...
Philips Elevate Plus AI Ultrasound Upgrade Receives FDA Clearance
Philips' new upgrade version, Elevate Plus, for its EPIQ Elite and Affiniti ultrasound systems has r...
Stryker Launches TPX HD Bone Power Tool with 296% Torque Increase and 40% Speed Boost
Stryker has launched the new TPX HD small bone power tool, designed to support complex orthopedic su...
U.S. MiniMed Partners with Abbott to Develop Glucose-Ketone Dual-Function Sensor
MiniMed (a Medtronic diabetes technology spin-off) disclosed during its first earnings call since go...
Eli Lilly and Ascidian Partner in Over $1.9 Billion Deal to Develop RNA Editors for Genetic Kidney Disease
Eli Lilly has entered into a global research collaboration with Ascidian Therapeutics to jointly dev...
AstraZeneca liver cancer combination therapy reduces risk of progression or death by 30%
Results from AstraZeneca's Phase III Emerald-3 trial showed that the regimen of durvalumab combined ...
Genetically Modified Hookworms Turned into Drug Factories by Washington University School of Medicine in St. Louis
Researchers at Washington University School of Medicine in St. Louis have successfully genetically m...
AI and Machine Learning Technologies Revolutionize Spine Care in the U.S.
In Fremont, California, artificial intelligence (AI) and machine learning (ML) technologies are driv...
Medical Simulation Technology Drives Standardization of Medical Training and Enhances Patient Safety
Medical simulation is driving the standardization of medical training and significantly improving pa...
Athenahealth Launches Over 80 AI RCM Features in the US
Athenahealth has launched over 80 new artificial intelligence features for revenue cycle management ...
Microsoft and Mayo Clinic Announce Collaboration to Develop Medical AI Models
Mayo Clinic and Microsoft have entered into a strategic partnership to jointly develop and deploy a ...
US Study: AI Slice Reconstruction Improves DBT Specificity to 94.9%
A recent retrospective study published in Radiology evaluated the impact of AI-driven slice reconstr...
Qwadra Secures Exclusive License for BEGO Medical's 3D Conveyor Belt Printing Technology for Foot Orthotics
PodoPrinter parent company Qwadra has entered into an exclusive licensing agreement with BEGO Medica...
Canada's NeuroThera Acquires 54% Stake in CliniQuantum for Approximately $9.45 Million
NeuroThera Labs Inc. (TSXV: NTLX) announced the completion of its acquisition of approximately 54.01...
Suzhou Eight Horses Superconducting Delivers First 230MeV Helium-Free Cyclotron Superconducting Magnet System
On June 3, 2026, the "230MeV Helium-Free Cyclotron Superconducting Magnet System" independently deve...
Canada's NodeAI Launches AI Trial to Enhance Lung Cancer EBUS Diagnostic Accuracy
NodeAI recently launched a clinical trial at the University Health Network (UHN) to validate the abi...
Novartis's Secukinumab Phase III Trial Shows Sustained Remission Rate Twice That of Placebo
Novartis has announced new data from the Phase III REPLENISH trial evaluating Cosentyx (secukinumab)...
U.S. Actinium Company's ATNM-400 Achieves 94.29% Tumor Inhibition Rate in Prostate Cancer Model
The radioconjugate ATNM-400 demonstrated superior antitumor activity compared to existing PSMA-targe...
Australia's Lumos FebriDx Commercialized Across Over 100 Institutions in 18 U.S. States
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has achieved initial progress in the U.S. commer...
UK's Elementis Completes Sale of Pharmaceutical Manufacturing Business for €34.3 Million
Elementis plc has announced the completion of the sale of its pharmaceutical manufacturing business ...
Germany's System Akvile Launches Pimsy Digital Entity
System Akvile, a digital skin health company whose platform has over one million users, has launched...
Ultragenyx to Participate in Goldman Sachs Global Healthcare Conference
On June 3, U.S. biopharmaceutical company Ultragenyx Pharmaceutical announced that its President and...
Australia's PME Renews $16 Million, Five-Year Contract with Ohio State University Wexner Medical Center
PRO MEDICUS LIMITED (ASX:PME) has renewed a five-year, $16 million contract with The Ohio State Univ...
Mexico's IMSS-B Invests 13 Billion Pesos to Purchase 32,000 Medical Devices
Alejandro Svarch Pérez, head of the Mexican Social Security Institute's Welfare System (IMSS Bienest...